These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9679209)

  • 21. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates.
    Roden DM
    Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic management of arrhythmias.
    Bink-Boelkens MT
    Pediatr Cardiol; 2000; 21(6):508-15. PubMed ID: 11050274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
    Cosío FG; Delpón E
    Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
    [No Abstract]   [Full Text] [Related]  

  • 26. Is antiarrhythmic treatment in the elderly different? a review of the specific changes.
    Deneer VH; van Hemel NM
    Drugs Aging; 2011 Aug; 28(8):617-33. PubMed ID: 21812498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmias and antiarrhythmic agents.
    Heddle WF; Tonkin AM
    Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond.
    Pürerfellner H
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):79-91. PubMed ID: 15320809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.
    McCauley M; Vallabhajosyula S; Darbar D
    Card Electrophysiol Clin; 2016 Jun; 8(2):481-93. PubMed ID: 27261836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proarrhythmia in patients treated for atrial fibrillation or flutter.
    Falk RH
    Ann Intern Med; 1992 Jul; 117(2):141-50. PubMed ID: 1605429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Class-I antiarrhythmic drugs].
    Kuga K; Sugishita Y
    Nihon Rinsho; 1996 Aug; 54(8):2110-6. PubMed ID: 8810785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic blockers in the prevention of sudden death.
    Frishman WH; Laifer LI; Furberg CD
    Cardiovasc Clin; 1985; 15(3):249-64. PubMed ID: 2421902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.